David Spiegel, M.D, PhD

Professor of Chemistry and Pharmacology at Yale University

Speaker

David Spiegel, MD, PhD is a Professor at Yale University with appointments in thedepartments of Chemistry and Pharmacology. The central focus of Professor Spiegel’sresearch has been developing novel mechanisms for drug action with a particular focuson modulating immune function. He has been recognized for his achievements with theNIH Director’s New Innovator Award, the DARPA HEALR award, the Department ofDefense Era of Hope Scholar Award, the Ellison Medical Foundation New Scholar Awardin Aging Research, the Novartis Early Career Award in Organic Chemistry, the Bill andMelinda Gates Foundation Grand Challenges Explorations Award, the Alfred P. SloanFoundation Fellowship and others. He is the cofounder of Kleo Pharmaceuticals (acquired2021), Kymera Therapeutics (NYSE: KYMR), Moda Pharmaceuticals (acquired 2021),Magnet Biotherapeutics, Revel Pharmaceuticals, Lysin Therapeutics and the SOAR Bioaccelerator.